Correction: Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells

Ruiqi Chen; Yinan Li; Ralph Buttyan; Xuesen Dong

doi:10.18632/oncotarget.25759

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells

PDF | How to cite

Oncotarget. 2018; 9:29842-29842. https://doi.org/10.18632/oncotarget.25759

Metrics: PDF 1543 views | ?

Ruiqi Chen¹, Yinan Li¹, Ralph Buttyan¹ and Xuesen Dong¹

¹Vancouver Prostate Center, Department of Urologic Sciences, The University of British Columbia, Vancouver, Canada

Published: July 03, 2018

This article has been corrected: The corrected author name is given below:

Ruiqi Chen

Original article: Oncotarget. 2017; 8:84863-84876. DOI: https://doi.org/10.18632/oncotarget.19386.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25759

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells